What Researchers Did
Researchers reviewed existing clinical evidence on hyperbaric oxygen therapy (HBOT), its mechanisms, indications, and safe applications, particularly for chronic wounds like diabetic ulcers and delayed radiation injury.
What They Found
The review found that HBOT, by improving oxygenation and reducing inflammation, supports wound healing and can decrease negative outcomes such as amputation. It specifically explored evidence for HBOT in treating arterial insufficiencies, diabetic ulcers, delayed radiation injury, and chronic refractory osteomyelitis.
What This Means for Canadian Patients
For Canadian patients suffering from chronic wounds like diabetic foot ulcers, arterial insufficiencies, or complications from radiation therapy, HBOT may offer a valuable adjunctive treatment option. This therapy could help improve wound healing and potentially reduce the risk of severe outcomes such as limb amputation.
Canadian Relevance
This article covers conditions such as diabetic foot ulcers and chronic refractory osteomyelitis, which are Health Canada-recognized indications for hyperbaric oxygen therapy.
Study Limitations
As a general review article, this study synthesizes existing information without presenting new research data or a systematic analysis of all available evidence.